🕵️ Terns Pharmaceuticals, Inc. ($TERN)
SEC insider & ownership activity, last 12 months · CIK 1831363 · every row links its SEC filing
Over the last 12 months insiders sold $7.1M with no open-market buying against it. Amy L. Burroughs sold $6.5M (Jan–Mar). One red-flag 8-K in the window: Delisting notice (3.01), May 5, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $7.1M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Amy L. Burroughs | 0 | – | 8 | $6.5M | Mar 16, 2026 |
| Jill M. Quigley | 0 | – | 1 | $441K | Nov 4, 2025 |
| Kuriakose Emil | 0 | – | 4 | $102K | Apr 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Soleus GP LLC | 9.6% | 13G | Feb 11, 2025 | filing ↗ | |
| Blackrock, Inc. | 6.8% | 13G | Feb 5, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Amy Burroughs | $3.6M | Jan 15, 2026 | filing ↗ |
| Jill Quigley | $344K | Nov 4, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | May 5, 2026 | filing ↗ |
| Delisting notice (3.01) | May 5, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 5, 2026 | filing ↗ |
| Change of control (5.01) | May 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 5, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 16, 2026 | filing ↗ |
| Earnings (2.02) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Other events (8.01) | Dec 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 8, 2025 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 3, 2025 | filing ↗ |
| Other events (8.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Other events (8.01) | Oct 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 21, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |